School of Medicine
Showing 1,401-1,450 of 2,393 Results
-
Tamara Montacute, MD, MPH
Clinical Associate Professor, Medicine - Primary Care and Population Health
BioTamara Kailoa Montacute is a board certified Family Medicine physician. She enjoys taking care of the entire family (including kids), and has special interest in women’s health, adolescent health, community health, chronic disease management, mental health and office based procedures. She also speaks Spanish.
She was born in New Zealand, grew up in England and moved to Seattle when she was twelve. Prior to attending medical school at Stanford, she completed her Masters in Public Health at Columbia University and spent several years working on public health programs in Mexico, Panama, Ethiopia and Rwanda. After medical school, she completed a Family Medicine Residency at O’Connor Hospital in San Jose. She is the co-medical director of Arbor Free Clinic, teaches several primary care focused medical student courses and spends part of her time caring for patients at the Samaritan House Free Clinics in Redwood City and San Mateo.
Outside the clinic, she enjoys hiking, biking, gardening and playing with her daughter and 2 dogs. -
Samuel Montalvo
Postdoctoral Scholar, Cardiovascular Medicine
BioAs a clinical exercise physiologist and sport biomechanist, I am dedicated to advancing human exercise and sports performance. I hold certifications as a Performance and Sport Scientist (CPSS) and as a Strength and Conditioning Specialist with Distinction (CSCS, *D) from the National Strength and Conditioning Association (NSCA). In 2022, I was honored with the Wu Tsai Human Performance Alliance Post-Doctoral Research Fellowship and a T32 Post-Doctoral Fellowship, Research Training in Myocardial Biology (TIMBS) at Stanford University.
My research focuses on understanding the mechanical, molecular, and physiological mechanisms that underpin human performance. I am also committed to developing innovative and practical training methods to enhance exercise and sports performance. Currently, I am a member of the Stanford Bioinformatics Core, contributing to the NIH-funded Molecular Transducers of Physical Activity Consortium (MoTrPAC) project. In this capacity, I analyze extensive clinical and exercise datasets, as well as multi-omic, multi-tissue, multi-exercise modality, and multi-species data, to uncover new insights into the biological mechanisms of physical activity and its impact on human health and performance.
In addition to my primary research focus, I collaborate with several teams at Stanford on projects involving Sports and Electrocardiography, Cardiopulmonary Exercise Testing, Exercise and Neuromuscular Disease, and the Stanford Baseball Team.
Beyond research, I am deeply committed to teaching and mentoring. As a first-generation college graduate and a Mexican-American with Indigenous heritage, I bring a unique perspective to my work, which informs my dedication to creating supportive and inclusive spaces for underrepresented groups in science and education. I serve as a Post-Doc Mentoring Coach in collaboration with the Stanford Office of Postdoctoral Affairs, where I facilitate bi-weekly workshops on mentoring for postdocs. I am also part of the Stanford PRISM program, which promotes opportunities for postdoctoral scholars. Furthermore, I mentor prospective and current medical students through the MAVERICs program (Metascience Analyses and Explorations of Reproducibility in Cardiovascular Science) as part of the Stanford Cardiovascular Institute, supporting their growth in cardiovascular research.
These experiences reflect my dedication to fostering an inclusive and supportive academic environment. My long-term goal is to become a professor, combining my passion for research, education, and mentoring the next generation of scientists to advance the fields of exercise physiology, multi-omics, and sports science. -
Maria Emilia Montez Rath
Assistant Professor (Research) of Medicine (Nephrology)
BioDr. Montez-Rath completed her PhD in Biostatistics from Boston University in 2008 focusing on methods for modeling interaction effects in studies involving populations with high levels of comorbidity, such as persons on dialysis. She is a senior biostatistician and director of the Biostatistics Core of the Division of Nephrology at Stanford University where she has been collaborating with faculty and fellows since 2010 to study a variety of research questions relevant to kidney disease. Her methodological interests are mainly data-driven and include the handling of missing data, survival analysis with an emphasis on models for time-varying covariates and competing risks, methods for analyzing epidemiologic studies, analysis of correlated data and comparative effectiveness studies, as well as data visualization.
-
Joshua Mooney
Clinical Assistant Professor, Medicine - Pulmonary, Allergy & Critical Care Medicine
Current Research and Scholarly InterestsOutcomes and Health Services Research in Advanced Lung Disease & Lung Transplant
-
Andrew Reese Moore
Instructor, Medicine - Pulmonary, Allergy & Critical Care Medicine
Current Research and Scholarly InterestsI am co-mentored by Dr. Angela Rogers and Dr. Purvesh Khatri. My research focuses on leveraging machine learning on multi-omic data to evaluate the immune response in critical illness. It is striking that despite many years of studying infections, we still treat patients with severe infections the same as we did 30 years ago, with antimicrobials, fluids, and supportive care. The goal of my research is to bring the ideals of precision medicine to critical care. In particular, I am working to better quantify how the immune system responds to infections with the goal of being able to "read" the immune system and treat patients with the medications they need to successfully recover.
-
Nancy Morioka-Douglas, MD, MPH
Clinical Professor, Medicine - Primary Care and Population Health
Current Research and Scholarly Interests--Community outreach to underserved populations to address health care disparities, chronic illness prevention, and health promotion.
--Chronic illness care: implementing optimal care for these patients and training the next generation of physicians in these best practices.
--Enhancing physician and staff satisfaction in caring for patients -
Emma C Morton-Bours
Affiliate, Medicine - Primary Care and Population Health
BioStanford Adjunct Clinical Assistant Professor--Primary Care and Population Health--Present
Caras Health--Present
Brigham & Women's Hospital, Harvard Medical School Teaching Award, Chief Medical Resident, 2004
Stanford University School of Medicine, Allen Barbour Award, 2000
Princeton University, BA Molecular Biology, Summa Cum Laude, 1994 -
Tia Moscarello, MS, LCGC
Staff, Medicine - Med/Cardiovascular Medicine
Clinical Associate Professor (Affiliated) [Shc], Pediatrics - GeneticsBioLicensed and certified genetic counselor with a specialization in inherited cardiovascular disease. Primary genetic counselor for the first on-call cardiovascular genetic counseling service. Clinical instructor for the Stanford University MS in Human Genetics and Genetic Counseling Program.
-
Dora G. Moscoso
AA and Postdoc Coordinator, Medicine - Med/Blood and Marrow Transplantation
Current Role at StanfordAA/Postdoctoral Fellowship Coordinator
-
Carson T. Moss
Affiliate, Department Funds
Resident in MedicineBioDr. Carson T. Moss is an Internal Medicine resident at Stanford and incoming Pulmonary and Critical Care Medicine fellow, starting in 2026. He has contributed to multicenter clinical trials including STOP-BOS, ATHOS-III, and PETAL-ROSE. His clinical and research focus centers on pulmonary complications in immunocompromised patients, with particular expertise in bronchiolitis obliterans syndrome (BOS), a rare manifestation of chronic graft-versus-host disease (cGVHD) following allogeneic hematopoietic stem cell transplantation. His work with Dr. Joe Hsu has been published in Blood Advances and Transplantation and Cellular Therapy, with findings presented at annual ATS meetings.
-
Eric Mou, MD
Postdoctoral Medical Fellow, Oncology
BioI was born in Oregon and raised in Iowa, where I cultivated my initial interest in science and medicine. I completed my undergraduate degree and medical school at the University of Iowa before heading to Stanford University for my internal medicine residency and oncology fellowship training. I chose this field to try my best in assisting patients during times of great need, and working to understand what is of greatest importance to them as they navigate their unique journey of cancer care. My clinical focus is in the care of patients with lymphoma and other hematologic cancers. My scholarly interests include better understanding the efficacy cancer therapeutics, improving patients' experience as the proceed through treatment, and promoting strength in medical education.
-
Salvinaz Islam Moutusy
Postdoctoral Scholar, Immunology and Rheumatology
BioI am a medical scientist with expertise in basic biomedical research focusing on Microbiology and Immunology. After getting medical license from Bangladesh, I received MD in Medical Microbiology from BSMMU, Bangladesh and MS in Environmental Health Science from the University of Tokyo School of Medicine, Japan.
-
Meagan Moyer
Academic Staff - Hourly - CSL, Medicine - Primary Care and Population Health
BioI am a lecturer in the School of Medicine's Clinical Informatics Management master of science program. I co-instruct the autumn through spring quarters practicum courses. Students in my courses gain a foundational knowledge of health policy, learn from experts in the field of health technology, and complete a capstone project that brings together learnings from the entire program into a meaningful deliverable that furthers their career and the field of clinical informatics and digital health technology.
-
Alisa Mueller, MD, PhD
Assistant Professor of Medicine (Immunology and Rheumatology)
BioDr. Mueller is an Assistant Professor in the Division of Immunology and Rheumatology. As a physician-scientist, she leads a research laboratory investigating mechanisms that drive stromal pathology in rheumatoid arthritis and other chronic inflammatory conditions. Utilizing innovative techniques in immunology, genomics, and regenerative medicine, she and her team aim to develop novel therapeutic approaches to combat autoimmune diseases.
Dr. Mueller earned her MD and PhD degrees at Stanford University as part of the Medical Scientist Training Program where she investigated mechanisms regulating a mesenchymal progenitor population in skeletal muscle that mediates both healthy tissue regeneration and pathologic fibrosis. During her training, she was awarded predoctoral grants from the NIH National Institute on Aging and the California Institute of Regenerative Medicine. Her studies culminated in a first-author publication in Nature and co-authorship on publications in Cell and Nature Communications. Subsequently, she pursued medicine residency and rheumatology fellowship at Brigham and Women’s Hospital and Harvard Medical School where she explored mechanisms driving synovial fibroblast pathogenicity in rheumatoid arthritis. Her work led to the identification of non-canonical Wnt signaling as a critical mediator of RA synovial fibroblast inflammatory activation as well as the development of functional genomic screens to elucidate a broad set of novel therapeutic targets in inflammatory fibroblasts. Moreover, she has also led high-dimensional immunoprofiling studies to reveal underlying immune aberrations in patients with systemic sclerosis and elucidate biologic mechanisms catalyzing disease in patients with longstanding immune-related disorders of unknown etiology in partnership with the Undiagnosed Diseases Network. During her fellowship and instructorship, she received a Distinguished Fellow Award from the American College of Rheumatology as well as grants including the NIH NIAMS Mentored Clinical Scientist Research Career Development Award (K08), Rheumatology Research Foundation Scientist Development Award with the Malawista Endowment Distinction, Hearst Young Investigator Award, and Innovation Evergreen Fund Award. Her work has resulted in co-first author publications in the Journal of Clinical Investigation, Cell Reports Medicine, and ACR Open Rheumatology as well as as co-authorship on publications in Lancet Rheumatology and the New England Journal of Medicine.
In addition to her scientific endeavors, Dr. Mueller is also dedicated to providing high quality clinical care and education. She serves as an attending physician specializing in rheumatology where she mentors trainees in outpatient and inpatient settings and provides educational lectures. With an interdisciplinary team, she developed an interactive medical case on neurologic manifestations of lupus which was published in the New England Journal of Medicine. She was awarded an Arnold Dunne Award for Compassion and Dedication to Patient Care at Brigham and Women’s Hospital. By pursuing basic and translational research alongside clinical care, Dr. Mueller and her team strive to uncover basic mechanisms regulating stromal biology in autoimmune and inflammatory disease development and to create diagnostic strategies and targeted therapeutics that will benefit patients who do not respond to conventional therapies. -
Lori Muffly
Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy)
Current Research and Scholarly InterestsDr. Muffly's interests include investigator initiated clinical trials focused on cellular therapies for adults with acute lymphoblastic leukemia and acute myeloid leukemia. She also has an active health outcomes research program focused on patterns of care and improving access to care for adults with acute leukemia.
-
Ann Mullally
George E. Becker Professor in Medicine
Current Research and Scholarly InterestsDr. Ann Mullally's aboratory studies the genetics, biology and therapy of myeloid blood cancers, with a focus on myeloproliferative neoplasms (MPN). Using primary human samples, mouse models, genomics, single-cell sequencing and CRISPR, as well as cellular and molecular biology, the lab has investigated the key genetic events underlying MPN pathogenesis. Dr. Mullally’s lab elucidated the mechanism by which mutant calreticulin (CALR) is oncogenic and causes MPN.
-
Mark Musen
Stanford Medicine Professor of Biomedical Informatics Research, Professor of Medicine (Biomedical Informatics) and of Biomedical Data Science
Current Research and Scholarly InterestsModern science requires that experimental data—and descriptions of the methods used to generate and analyze the data—are available online. Our laboratory studies methods for creating comprehensive, machine-actionable descriptions both of data and of experiments that can be processed by other scientists and by computers. We are also working to "clean up" legacy data and metadata to improve adherence to standards and to facilitate open science broadly.
-
Jonathan N. Myers
Clinical Professor (Affiliated), Medicine - Med/Cardiovascular Medicine
BioDr. Myers is a Health Research Scientist at the Palo Alto VA Health Care System; a Clinical Professor at Stanford University (Affiliated), and a Senior Research Career Scientist Award recipient through the VA Rehabilitation Research and Development Program. His research has focused on primary and secondary prevention, and the clinical applications of exercise testing and rehabilitation in patients with cardiovascular disease and other chronic conditions. He has a lengthy history of studying the epidemiology of cardiopulmonary exercise test responses, physical activity patterns, and other lifestyle factors and their relation to health outcomes. He manages the Veterans Exercise Testing Study (VETS), an ongoing, prospective evaluation of Veteran subjects referred for exercise testing for clinical reasons, designed to address exercise test, clinical, and lifestyle factors and their association with health outcomes.
He earned his bachelor’s degree from the University of California, Santa Barbara, his master's degree from San Diego State University, and his doctorate from the University of Southern California. He has been a board member for many organizations including the American Heart Association (AHA), the American Association of Cardiovascular and Pulmonary Rehabilitation (AACVPR), and the American College of Sports Medicine (ACSM), and serves on the editorial board for 9 journals. He is a recipient of the Michael Pollock Established Investigator Award through the AACVPR, a recipient of the Steven N Blair Award for excellence in physical activity research from the AHA Council on Epidemiology and Prevention and is the 2022 recipient of the American College of Sports Medicine Citation Award. He is a fellow of the AACVPR, ACSM, American College of Cardiology, and the AHA, and has authored and co-authored guidelines on exercise testing and rehabilitation for each of these organizations, including the 2021 editions of the ACSM and AACVPR guidelines. -
Michitaka Nakano
Basic Life Research Scientist, Medicine - Med/Hematology
BioI am a MD/PhD postdoctoral fellow and medical oncologist with a long-standing interest in translational cancer research. My long-term goal is to be a lab-based physician-scientist and independent academic researcher, translating basic cancer research, and mentoring next-generation scientists. My thesis work in Japan focused on cancer stem cell equilibrium by uniquely applying organoid culture as a method to elucidate cancer stem cell dynamics, which was awarded in Japanese Cancer Association. Along with the development of the field represented by success in T cell checkpoint, my interest gradually shifted to immune oncology while I examined numerous numbers of cancer patients as a medical oncology fellow. My postdoctoral fellowship at Calvin Kuo Lab in Stanford (2019-present) focuses on tumor immune microenvironment. Kuo lab developed a unique 3D air-liquid interface (ALI) organoid system that cultures tumors while preserving their endogenous infiltrating immune cells (T,B ,NK, Myeloid cells). My postdoctoral work will prove the significance of organoids as a translational tool to discover tumor-immune interaction by novel checkpoint inhibitors for immune cells, which can be broadly applicable to basic cancer biology, precision medicine, therapeutics validation and biomarker discovery.
